|
2
|
- Base population
- By market (US, EU, Japan, ROW)
- Genetic predisposition toward disease
- Insurance coverage
- Target population
- Disease prevalence
- Disease severity
- Likelihood of seeing an MD
- Probability of use
- Percent of patients receiving Rx
- Likelihood of use of OTC
- Launch scenarios
- Market share model
- Product adoption model
- Revenue and margin projection
|